Skip to main content
WAVERLEY PHARMA INC. logo

WAVERLEY PHARMA INC. — Investor Relations & Filings

Ticker · WAVE ISIN · CA94357L1058 LEI · 254900VT8CXPPV1G5Q51 TSXV Manufacturing
Open in API
Filings indexed 110 across all filing types
Latest filing 2020-04-17 Regulatory Filings
Country CA Canada
Listing TSXV WAVE

About WAVERLEY PHARMA INC.

https://www.waverleypharma.com/

Waverley Pharma Inc. is a specialty biopharmaceutical company engaged in the research, development, and commercialization of safe, effective, and affordable therapeutics. The company primarily focuses on oncology, developing treatments such as poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer. Waverley Pharma commercializes its pharmaceutical products in markets including the United Kingdom, evidenced by successful tenders for drugs like Capecitabine with NHS Scotland. Furthermore, the company operates a retail pharmacy in the United States, integrating pharmaceutical innovation with direct patient service operations.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short notice from Computershare to Canadian Securities Regulatory Authorities regarding an upcoming Annual and Special Meeting of Security Holders for Waverley Pharma Inc. It provides meeting details such as dates, location, and voting information. The document does not contain any financial data, detailed reports, or results of the meeting. It is essentially an announcement about the meeting logistics and proxy material handling. Given the short length (1025 characters) and the nature of the content, this fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories like AGM Information or Proxy Solicitation, which would typically include more detailed materials or voting requests. Therefore, the best classification is Regulatory Filings (RNS).
2020-04-17 English
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed under securities regulations, announcing a material change related to the appointment of a new President and CEO and the authorization of stock options. It is not a full financial report but a regulatory announcement of a management change and related stock option grant. The content fits the category of Board/Management Information (MANG) as it announces changes in senior management and board-related decisions. The document length is short and focused on management changes, not financial results or detailed reports.
2020-02-03 English
Material change report - English.pdf
Board/Management Information Classification · 100% confidence The document is a Material Change Report filed under Form 51-102F3, which is a regulatory filing used to disclose significant changes in a company. The content details resignations and appointments in senior management positions (CEO and CFO). It does not contain financial statements or detailed financial analysis, but rather announces management changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short and focused on management changes, not a full report or announcement of a report publication. Therefore, the correct classification is MANG.
2020-02-03 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document announces the appointment of a new President and CEO by the board of directors, including details about the individual's background and the granting of stock options. There is no financial data, no report or presentation attached, and no mention of voting results or regulatory filings. The content clearly relates to a change in senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification.
2020-02-03 English
News release - English.pdf
Regulatory Filings
2020-01-08 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.